Nebula Research & Development »

Intra Cellular Therapies shares owned by Nebula Research & Development

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2023-09-30 $337k 6.5k 52.09
2023-03-31 $214k 4.0k 54.15